Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / MRSN - Mersana Therapeutics: On Hold While Waiting For Any Positive News

MRSN - Mersana Therapeutics: On Hold While Waiting For Any Positive News

Mersana Therapeutics Inc.

2024-05-15 09:56:00 ET

Summary

  • Mersana Therapeutics, Inc. is a cancer-focused biotech with two pipeline projects in phase 1 clinical study.
  • Their lead compounds, XMT-1660 and XMT-2056, target novel immune checkpoints and HER2, respectively.
  • The company has enough cash to support trials in the near term, but faces high risks and needs to prove the success of their pipeline candidates.

Topline Summary

For further details see:

Mersana Therapeutics: On Hold While Waiting For Any Positive News
Stock Information
Company Name: Mersana Therapeutics Inc.
Stock Symbol: MRSN
Market: NASDAQ
Website: mersana.com
Menu
MRSN MRSN Quote MRSN Short MRSN News MRSN Articles MRSN Message Board
Get MRSN Alerts

News, Short Squeeze, Breakout and More Instantly...